|
|
|
|
|
Immunology Newsletter
|
|
|
|
Research News
|
Vanderbilt researchers identify potent antibodies against HIV. read more
Nanoparticles show promise for treating intestinal inflammation, study finds. read more
Drug combination developed to treat for human parainfluenza virus. read more
HIV can develop resistance to CRISPR/Cas9. read more
New mouse model to aid testing of Zika vaccine, therapeutics. read more
Targeting the gut microbiome to fight heart disease. read more
Promising new method inhibits TB-causing bacteria. read more
|
|
|
|
|
|
|
ADVERTISEMENT
|
|
A validated CD19 antibody for flow cytometry
|
|
Finally a great CD19 antibody for flow! CD19 UltraMAB (clone UMAB103) with specificity validated by protein microarrays demonstrates superior sensitivity and specificity for CAR-T cell research, especially for flow cytometry.read more
|
|
|
|
|
DEXTRAN SULFATE SODIUM SALT (6,000-8,000 M.Wt). read more
MILLIPLEX® MAP Multiplex panels for Immunology, Metabolism, CVD, Cancer, Neuroscience, Bone and Toxicity, and Other Circulating and Intracellular Biomarkers. read more
|
|
|
Promotion
|
|
Stain protein gels in 10 minutes
|
|
Get 50% off and stain your gel for under 50-cents! AcquaStain is a single-step Coomassie-based stain. No wash. No destain. Labs throughout North America love it. Sensitive! Fast! Easy! Environmentally-friendly! Affordable! If you've not switched yet, why wait? We know you'll love it too. Use promo ... read more
|
|
|
More Promotions »
|
|
|
|
|
Event
|
|
Immunogenicity
|
|
Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. With the global vaccine market expected to reach $84.44 billion by... read more
|
|
|
More Events »
|
|
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA
|
|
You received this email because you are subscribed
to our database. Need to change your settings?
Email Settings or
Unsubscribe
|
|
